3-aminobenzamide has been researched along with vidarabine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Dahlberg, WK; Little, JB; Ueno, AM | 1 |
| Kelland, LR; Steel, GG | 1 |
| Smit, JA; Stark, JH | 1 |
| Allen, PD; Kelsey, SM; Newland, AC; Richardson, DS | 1 |
| Joiner, MC; Marples, B | 1 |
| Cawley, JC; Pettitt, AR; Sherrington, PD | 1 |
7 other study(ies) available for 3-aminobenzamide and vidarabine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Differential response of human and rodent cell lines to chemical inhibition of the repair of potentially lethal damage.
Topics: Adenosine Diphosphate Ribose; Animals; Aphidicolin; Benzamides; Cell Line; Cricetinae; Cricetulus; Cytarabine; Diterpenes; DNA Polymerase II; DNA Repair; Fibroblasts; Humans; Hydroxyurea; Mice; Vidarabine | 1989 |
Modification of radiation dose-rate sparing effects in a human carcinoma of the cervix cell line by inhibitors of DNA repair.
Topics: Aphidicolin; Benzamides; Caffeine; Cell Line; Cobalt Radioisotopes; Diterpenes; DNA Repair; Female; Humans; Hydroxyurea; In Vitro Techniques; Novobiocin; Radiation Dosage; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vidarabine | 1988 |
Inhibiting the repair of DNA damage induced by gamma irradiation in rat thymocytes.
Topics: Animals; Antineoplastic Agents; Aphidicolin; Benzamides; Cytarabine; DNA Damage; DNA Repair; Doxorubicin; Flavonoids; Gamma Rays; Kinetics; Naphthoquinones; Novobiocin; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; T-Lymphocytes; Time Factors; Vidarabine | 1994 |
Effects of PARP inhibition on drug and Fas-induced apoptosis in leukaemic cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; fas Receptor; Genes, MDR; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Microtubules; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
Modification of survival by DNA repair modifiers: a probable explanation for the phenomenon of increased radioresistance.
Topics: Animals; Antimetabolites; Benzamides; Cell Line; Cell Survival; Colony-Forming Units Assay; Cricetinae; Cricetulus; DNA Repair; Dose-Response Relationship, Radiation; Enzyme Inhibitors; Fast Neutrons; Novobiocin; Nucleic Acid Synthesis Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Radiation Tolerance; Radiation-Sensitizing Agents; Topoisomerase II Inhibitors; Vidarabine; X-Rays | 2000 |
Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Membrane; Cell Size; Cladribine; DNA Fragmentation; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tumor Suppressor Protein p53; Vidarabine | 2000 |